George P. Patrinos
George P. Patrinos
Contributor, The Yuan

Dr George Patrinos is professor of pharmacogenomics and pharmaceutical biotechnology at the University of Patras, Greece. He holds adjunct professorships at the Faculty of Medicine, Rotterdam, the Netherlands and the Department of Pathology at the United Arab Emirates University. His group consists of more than 35 staff members from graduate students to post-doctoral scientists, covering disciplines from wet and dry lab and public health genomics projects, all focusing on pharmacogenomics and personalized medicine. George has more than 270 publications in peer-reviewed leading scientific journals, such as Nature Genetics, Nature Rev Genet and Nucleic Acids Res. He is Editor-in-Chief of the Pharmacogenomics Journal.

Drug Design, Development and Repositioning with AI
Game-Changer
Pharma companies are in constant need of novel technologies for drug design and development especially in the modern digital health era. To this end, AI, neural networks and machine learning will play a crucial role in the design and development of new drugs as well as drug repurposing/repositioning. As such, this new discipline holds promise and has slowly begun to revolutionize pharmaceutical industry, in concert with -omics technologies.
George P. Patrinos,  |  Jun 30, 2021